Honz Pharmaceutical Co., Ltd. (SHE:300086)

Honz Pharmaceutical Revenue

Honz Pharmaceutical had revenue of 96.57M CNY in the quarter ending March 31, 2026, a decrease of -14.09%. This brings the company's revenue in the last twelve months to 450.28M, down -5.64% year-over-year. In the year 2025, Honz Pharmaceutical had annual revenue of 466.12M, down -0.72%.

• Revenue (ttm): 450.28M
• Revenue Growth: -5.64%
• P/S Ratio: 6.66
• Revenue / Employee: 833.85K
• Employees: 540
• Market Cap: 3.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	466.12M	-3.40M	-0.72%
Jan 1, 2025	469.53M	-270.04M	-36.51%
Dec 31, 2023	739.57M	203.82M	38.05%
Jan 1, 2023	535.75M	-300.82M	-35.96%
Jan 1, 2022	836.57M	-85.08M	-9.23%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error